Log in
Enquire now
Bloom Science

Bloom Science

Developing innovative therapies focused on microbiome gut-brain axis.

OverviewStructured DataIssuesContributors

Contents

bloomscience.co
bloomscience.com
Is a
Organization
Organization
Company
Company

Company attributes

Industry
Engineering
Engineering
Proteomics
Proteomics
Microbiome
Microbiome
Technology
Technology
Biology
Biology
Biotechnology
Biotechnology
Biomedical engineering
Biomedical engineering
Location
United States
United States
San Diego
San Diego
California
California
B2X
B2B
B2B
Pitchbook URL
pitchbook.com/profiles...229019-77
Number of Employees (Ranges)
1 – 10
Email Address
info@bloomscience.com
Full Address
Roselle St, San Diego, California 92121, US0
Investors
Joyance Partners
Joyance Partners
Apollo Ventures
Apollo Ventures
ALS Investment Fund
ALS Investment Fund
Leaps by Bayer
Leaps by Bayer
Founded Date
2018
0
Total Funding Amount (USD)
12,000,000
Latest Funding Round Date
December 9, 2021
Latest Funding Type
Series A
Series A
Country
United States
United States

Other attributes

Company Operating Status
Active
Latest Funding Round Amount (USD)
12,000,000
Public/Private
Private

Our bodies are home to trillions of microbes that impact our health. We’re comprised of around ten times more microbial cells than human cells, and advancing research is uncovering the role that these microbes play in regulating brain behavior, development and function.

The gut-immune-brain axis is a multi-directional signaling link between the microbiota in the gastrointestinal tract, the immune system, and the brain. Complex pathways of the resident microbes and host systems interact to drive function in the cognitive and emotional centers in the brain. Microbes modulate neuroinflammation as well as host levels of neuroactive molecules, including neurotransmitters and neuropeptides, that affect complex behaviors, such as social, communicative, emotional, and anxiety-like behaviors.

There is increasing data to understand how the gut microbiota influences and contributes to the pathogenesis of many neurological disorders. In many cases, alterations in the microbial communities that inhabit us or microbial dysbiosis, are further implicated in a variety of neurological disorders, including epilepsy, Amyotrophic Lateral Sclerosis, dementia, and Alzheimer’s.

Timeline

No Timeline data yet.

Funding Rounds

Products

Acquisitions

SBIR/STTR Awards

Patents

Further Resources

Title
Author
Link
Type
Date

Bloom Science Raises $12M in Series A

https://www.sdbj.com/news/2021/dec/23/bloom-science-raises-12m-series/

Web

References

Find more companies like Bloom Science

Use the Golden Query Tool to find similar companies in the same industry, location, or by any other field in the Knowledge Graph.
Open Query Tool
Access by API
Golden Query Tool
Golden logo

Company

  • Home
  • Press & Media
  • Blog
  • Careers
  • WE'RE HIRING

Products

  • Knowledge Graph
  • Query Tool
  • Data Requests
  • Knowledge Storage
  • API
  • Pricing
  • Enterprise
  • ChatGPT Plugin

Legal

  • Terms of Service
  • Enterprise Terms of Service
  • Privacy Policy

Help

  • Help center
  • API Documentation
  • Contact Us
By using this site, you agree to our Terms of Service.